Association between syphilis, antibodies to herpes simplex virus type 2, and recreational drug use and hepatitis B virus infection in the women's interagency HIV study

Clinical Infectious Diseases

Volumn 39, Issue 9, 2004, Pages 1363-1370

  Tien, Phyllis C ^a,b,h   Kovacs, Andrea ^c   Bacchetti, Peter ^a   French, Audrey L ^d   Augenbraun, Michael ^e   Cole, Stephen R ^g   Hessol, Nancy ^a   Justman, Jessica ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d Jr Hospital of Cook County   (United States)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; GENITAL ULCER; HEALTH EDUCATION; HEPATITIS B; HERPES SIMPLEX VIRUS 2; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; INFECTION RISK; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEXUAL TRANSMISSION; SYPHILIS; VACCINATION;

ADULT; ANTIBODIES, VIRAL; COHORT STUDIES; FEMALE; HEPATITIS B; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HUMANS; MULTIVARIATE ANALYSIS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; SYPHILIS;

EID: 7644244320     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/424879     Document Type: Article

References (24)

1. Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001; 32:492-7.
2. Cohen M, French AL, Benning L, et al. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med 2002; 113:91-8.
3. Ockenga J, Tillmann H, Trautwein C, Stoll M, Manns MP, Schmidt R. Hepatitis B and C in HIV-infected patients. J Hepatol 1997; 27:18-24.
4. Thio C, Seaborg E, Skolasky R, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002; 360:1921-6.
5. Franks A, Berg C, Kane M, et al. HBV Infection among children born in the U.S. to Southeast Asian refugees. New Engl J Med 1989; 321: 1301-5.
6. Murrill C, Weeks H, Castrucci B, et al. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health 2002; 92:385-7.
7. Rosenblum L, Darrow W, Witte J, et al. Sexual practices in the transmission of hepatitis B virus and prevalence of hepatitis delta virus infection in female prostitutes in the United States. JAMA 1992; 267: 2477-81.
8. Gyarmathy VA, Neaigus A, Miller M, Friedman SR, Des Jarlais DC. Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. J Acquir Immune Defic Syndr 2002; 30:448-56.
9. Feldman JG, Minkoff H, Landesman S, DeHovitz J. Heterosexual transmission of hepatitis C, hepatitis B, and HIV-1 in a sample of inner city women. Sex Transm Dis 2000; 27:338-42.
10. Hernandez MT, Klausner JD, McFarland W, et al. Hepatitis B prevalence in young women living in low-income areas: the population-based San Francisco bay area's young women's survey. Sex Transm Dis 2000; 27:539-44.
11. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Inter-agency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998; 9:117-25.
12. Hessol N, Schneider M, Greenblatt R, et al. Retention of women in a prospective study of human immunodeficiency virus infection: impact of race, unstable housing, and use of human immunodeficiency virus therapy. Am J Epidemiol 2001; 154:563-73.
13. Kellerman S, Hanson D, McNaghten A, Fleming P. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis 2003; 188:571-7.
14. Tayal S, Sankar K. Impaired response to recombinant hepatitis B vaccine in asymptomatic HIV-infected individuals. AIDS 1994; 8:558-9.
15. Hofer M, Joller-Jemelka HI, Grob PJ, Luthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis 1998; 17:6-13.
16. Piroth L, Binquet C, Vergne M, et al. The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepatol 2002; 36: 681-6.
17. Gandhi R, Wurcel A, McGovern B, et al. Low prevalence of ongoing hepatitis B viremia in HIV-positive individuals with isolated antibody to hepatitis B core antigen. J Acquir Immune Defic Syndr 2003; 34: 439-41.
18. Grob P, Jilg W, Bornhak H, et al. Serological pattern "anti-HBc alone": report on a workshop. J Med Virol 2000; 62:450-5.
19. De Maria N, Colantoni A, Friedlander L, et al. The impact of previous HBV infection on the course of chronic hepatitis C. Am J Gastroenterol 2000; 95:3529-36.
20. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando M, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341:22-6.
21. Royce R, Sena A, Gates W, Cohen M. Sexual transmission of HIV-1. N Engl J Med 1997; 336:1072-8.
22. Friedman SR, Flom P, Kottiri B, et al. Prevalence and correlates of anal sex with men among young adult women in an inner city minority neighborhood. AIDS 2001; 15:2057-60.
23. Rosenblum L, Hadler S, Castro K, et al. Heterosexual transmission of hepatitis B virus in Bell Glade, Florida. J Infect Dis 1990; 161:407-11.
24. Centers for Disease Control and Prevention. Recommendations for the prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep 1998; 47(RR-17):1-39.